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Abstract 
Background: It has been suggested there is a chronic neurodegenerative disorder, underlying the pathophysiology 
of multiple sclerosis (MS), which is distinct from the more obvious immune‑mediated attack on the white matter. Lim‑
ited data exists indicating there is an alteration in pulse wave propagation within the craniospinal cavity in MS, similar 
to the findings in normal pressure hydrocephalus (NPH). It is hypothesized MS may harbor pulse wave encephalopa‑
thy. The purpose of this study is to compare blood flow and pulse wave measurements in MS patients with a cohort 
of NPH patients and control subjects, to test this hypothesis.
Methods: Twenty patients with MS underwent magnetic resonance (MR) flow quantification techniques. Mean 
blood flow and stroke volume were measured in the arterial inflow and venous out flow from the sagittal (SSS) and 
straight sinus (ST). The arteriovenous delay (AVD) was defined. The results were compared with both age‑matched 
controls and NPH patients.
Results: In MS there was a 35 % reduction in arteriovenous delay and a 5 % reduction in the percentage of the arte‑
rial inflow returning via the sagittal sinus compared to age matched controls. There was an alteration in pulse wave 
propagation, with a 26 % increase in arterial stroke volume but 30 % reduction in SSS and ST stroke volume. The AVD 
and blood flow changes were in the same direction to those of NPH patients.
Conclusions: There are blood flow and pulsation propagation changes in MS patients which are similar to those of 
NPH patients. The findings would be consistent with an underlying pulse wave encephalopathy component in MS.
Keywords: Multiple sclerosis, Normal pressure hydrocephalus, Cerebral blood flow, Pulse wave encephalopathy, 
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Background
Multiple sclerosis (MS) is considered to be an autoim-
mune inflammatory demyelinating disease of the cen-
tral nervous system. The histopathology of MS shows 
inflammation to be most prominent in the white mat-
ter of the corpus callosum, subcortical white matter 
tracts, optic nerve and spinal tracts. There is T cell and 
macrophage-mediated damage leading to demyelina-
tion [1]. The immune-mediated aspects of MS dominate 
the research literature with all of the currently available 
therapies directed at modulating the immune response 
in this disease [2]. Despite the overwhelming dominance 
of the immune hypothesis in MS research, in a review of 
the literature, Juurlink noted that although the immune-
modulating therapies reduce the number and sever-
ity of exacerbations, they do not prevent the long-term 
progression toward disability in MS [3]. If the amount 
of brain inflammation occurring during the disease pro-
cess does not affect the degeneration, this suggests there 
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may be some neurodegenerative process, other than the 
inflammation, mediating the slow decline. Although 
the autoimmune response of the body could secondar-
ily elicit a neurodegenerative effect, in a major review 
Stys suggests that it was also possible that MS may be a 
degenerative disease that secondarily elicits an autoim-
mune response [4]. In the second scenario, the neurode-
generative disorder would perhaps lead to a breakdown 
of the blood–brain barrier and damage the myelin, thus 
leaving the myelin susceptible to immune attack in those 
individuals who were prone to such a response. Indeed, 
given that multiple sclerosis is characterized by simulta-
neous focal breakdown of the blood–brain barrier, the 
development of demyelinating lesions that are associ-
ated with immune-mediated inflammation and eventual 
axonal loss [3], it may be hard to discern which is the ini-
tiating event and which the secondary.
Multiple sclerosis has been noted to have some charac-
teristics in common with normal pressure hydrocephalus 
(NPH). On the basis of decreased intracranial compliance 
[5], increased ventricular [6] and Virchow–Robin space 
size [7], the presence of Hakim’s triad [8–10], increased 
pulsatility of the CSF through the aqueduct [11], reduced 
net flow of CSF through the same structure [12] together 
with decreased CSF pulsation at C2 level [13] (all of which 
are noted in NPH [3]), Juurlink suggested the possible 
initiating neurodegenerative process could be an under-
lying pulse wave encephalopathy [3]. Pulse wave enceph-
alopathy was a concept originally developed by one of 
the current authors to describe how three of the causes 
of dementia (Alzheimer’s disease, vascular dementia and 
normal pressure hydrocephalus) could be interrelated 
along a common pathophysiological spectrum [14]. The 
spectrum was suggested to be related to the strength of 
the pulse pressure waves induced in the craniospinal cav-
ity by the arterial tree and the way the pulse waves inter-
act with the compliance of the spinal canal and venous 
system [14]. It was hypothesized, increased arterial pulse 
pressure, if not damped sufficiently (either because it was 
too large or the available compliance of the spinal canal 
and/or veins too small), would lead to elevated capillary 
and venous pulse pressure and increased aqueduct pul-
sation (together with other pathological effects) [14]. 
However, the physiological evidence Juurlink has used 
to justify MS as being similar to NPH is tenuous at best. 
Firstly, Gorucu commented that the increase in stroke 
volume through the aqueduct in MS could be caused by 
hyperdynamic dilated ventricles secondary to the under-
lying atrophy [11]. Therefore, the increased aqueduct 
flow could be passive, rather than part of an active, pulsa-
tion driven process. Secondly, the estimation of net CSF 
flow through the aqueduct using MRI is currently under 
a cloud. Due to the very low flow rates being measured, 
the cumulative error in net aqueduct flow measurement 
is estimated to be up to 30  % [15]. Therefore, this may 
not be a valid metric. Finally, the reduced stroke volume 
through the spinal canal in MS was dismissed by the 
authors of the paper where it was originally described 
because there was also a reduction in the arterial blood 
flow in the MS patients. It was assumed there would have 
been an associated reduced arterial stroke volume and 
therefore less impetus to move the spinal canal CSF [13]. 
Therefore, much of the data is missing from the literature 
which would enable one to answer the question, “Is there 
an underlying pulse wave encephalopathy component in 
MS?” The required evidence includes an accurate meas-
ure of the total arterial pulsation stroke volume (which 
is the input into the system driven by pulse pressure), 
the intracranial compliance (which is the moderator of 
pulse pressure) and the stroke volume of the venous sys-
tem (which is an output of the system). The purpose of 
the current study is to measure these variables utilizing 
a phase contrast MRI technique directed to the arterial 
input and venous output in a cohort of MS patients and 
compare them with normal controls and NPH patients.
Methods
Subjects
Patients with multiple sclerosis (MS) are regularly fol-
lowed-up with routine MRI scans. As part of the standard 
protocol, MR flow quantification sequences were added 
to provide a surrogate marker of cerebral metabolism 
and brain volume. In the current study, twenty consecu-
tive relapsing remitting MS patients had these sequences 
reviewed, all were female. The demographic details are 
summarized in Table 1. The mean age was 43 ± 12 year. 
The mean length of time from first symptoms to the MRI 
was 13  ±  8  year. The mean audio recorded cognitive 
screen score was 85  ±  12. The mean extended disabil-
ity status scale for the patients was 2.5 ±  1.8. Seventeen 
patients were currently undergoing immunomodulation 
therapy at the time of the study; the other three had not 
received treatment for over a year. Twenty patients with 
NPH, who were previously studied with the same flow 
quantification technique (with the results being previously 
published in part [16]), were selected for comparison. 
This group comprised 12 males and 8 females. The NPH 
group was originally selected on the basis of the classical 
clinical triad of gait ataxia  ±  dementia  ±  incontinence 
together with ventriculomegaly. All 20 patients were con-
firmed to have NPH, having shown clinical improvement 
following CSF flow diversion (see [16] for more details). 
The controls were selected from a bank of spouses and 
volunteers recruited by advertisement and have been pre-
viously published [16, 17]. The controls were confirmed 
to be without structural brain pathology on standard 
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MRI and underwent Mini-Mental State examination and 
formal neuropsychological testing. The normal young 
were selected to match the MS patients and averaged 
43 ± 16 year, all were females. The normal elderly averaged 
74 ± 16 year and there were 6 women and 6 men.
MR and analysis
All patients were imaged on a 1.5 T superconduct-
ing magnet (Vario; Siemens, Erlangen Germany). In the 
brain, the patients were scanned with standard T1 and 
FLAIR sagittal images followed by T2 axial and diffusion-
weighted axial images. A 3D T1 post contrast series was 
acquired. In the neck, post contrast T1 sagittal, inversion 
recovery sagittal and T2 axial images were performed. 
Two MR phase contrast flow quantification sequences 
were acquired with retrospective cardiac gating. The TR 
was 26.5  ms, TE 6.9  ms, flip angle 15º, slice thickness 
5  mm, matrix 192 ×  512, FOV 150 and a single excita-
tion. The velocity encoding value was 75/s for the arte-
rial acquisition and 40 cm/s for the venous. The arterial 
plane was selected to pass through the vertical segments 
of the carotid and basilar arteries at the skull base. The 
venous plane was selected to pass through the sagittal 
sinus above the torcular and then pass through the mid 
part of the straight sinus (Fig. 1C–E). The planar imaging, 
as well as the flow quantification raw data, was archived 
on DVD discs.
Regions of interest were placed around the carotid 
arteries, basilar artery, the sagittal sinus and the straight 
sinus in each patient. Care was taken to exclude aliasing 
by retrospectively manipulating the base lines of each 
resultant graph giving an effective arterial flow limit of 
150  cm/s. Background subtraction was utilized to limit 
the effect of eddy currents. The addition of the flow from 
the three arteries gave the total arterial inflow. The sag-
ittal sinus and straight sinus outflow was obtained from 
the regions of interest placed around these vessels. The 
percentage of the arterial inflow drained by each sinus 
was calculated for each patient.
The arteriovenous delay (AVD) is the time taken 
between the center of the primary arterial pulse and the 
center of the primary sagittal sinus outflow pulse. The arte-
rial and venous waveforms were transected by a horizon-
tal line representing the mean blood flow for each graph. 
The midpoint between the two sites where the mean flow 
crosses the flow curve is taken to be the midpoint of the 
pulse wave. Subtracting the arterial and sagittal venous 
midpoints gave the AVD. This is inversely proportional to 
the pulse wave velocity between these two points (Fig. 1F, 
G). The arterial pulse volume represents the degree to 
which the arterial tree expands in systole and is calculated 
from the graphs obtained from each carotid and basilar 
artery. The mean blood flow velocity for each artery for the 
entire heartbeat was subtracted from the mean blood flow 
Table 1 Demographics and clinical information for multiple sclerosis patients
ARCS audio recorded cognitive screen; EDSS extended disability status scale; F female; RRMS,relapsing remitting multiple sclerosis
Patient number Age (years) Sex Duration of  
disease (years)
Type Treatment ARCS EDSS
1 21 F 9 RRMS Natalizumab 79 1.5
2 38 F 2 RRMS Interferon beta‑1a 100 0
3 57 F 4 RRMS Betaferon 73 1.5
4 36 F 11 RRMS Natalizumab 78 5.5
5 46 F 21 RRMS Natalizumab 81 6.0
6 62 F 17 RRMS Nil 72 6.5
7 40 F 16 RRMS Natalizumab 82 1.5
8 51 F 26 RRMS Nil 90 2.5
9 40 F 13 RRMS Natalizumab 77 3.5
10 31 F 9 RRMS Natalizumab 71 3.0
11 50 F 28 RRMS Nil 96 2.5
12 36 F 4 RRMS Natalizumab 83 1.0
13 46 F 4 RRMS Fingolimod 86 1.5
14 59 F 22 RRMS Fingolimod 60 1.5
15 36 F 4 RRMS Interferon beta‑1a 95 1.5
16 62 F 25 RRMS Glatiramer 93 1.5
17 47 F 14 RRMS Betaferon 92 1.0
18 31 F 9 RRMS Natalizumab 79 1.5
19 28 F 11 RRMS Natalizumab 93 1.5
20 48 F 5 RRMS Immunoglobulin 111 3.5
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velocity for the period of systole (systole was defined as the 
section of the graph between the transection points) for 
the same artery, giving the mean increase in flow velocity 
over systole for that vessel (Fig. 1F). This value when mul-
tiplied by the time taken for systole (the distance between 
transection points) to occur and the cross-sectional area of 
the vessel (region of interest) gives the volume of expan-
sion of that vessel in systole. The addition of the value of 
vessel expansion obtained for both carotid and the basi-
lar arteries gave the arterial stroke volume. The sagittal 
and straight sinus stroke volumes were obtained for each 
patient by a similar process to the arterial stroke volume 
except using the venous flow data (Fig. 1G). The percent-
age of the arterial stroke volume represented by each 
venous stroke volume was calculated.
Statistical analysis
Group means and standard deviations were obtained 
for each of the measurements. Comparison of mean 
differences between the study groups were tested using 
a general linear model–univariate analysis of variance 
(ANOVA). For each ANOVA, the measurement was 
entered as the dependent variable, with study group 
entered as a fixed factor and age entered as a covariate 
between study groups and relevant controls. All meas-
urements were checked for normality using the one-sam-
ple Komogorov–Smirnov test and for equality of variance 
using the Levene’s Test. A non-paired T test, with a p 
value of less than 0.05 was used to indicate statistical sig-
nificance. All statistical analyses were performed using 
IBM® SPSS Statistics V22.
Results
The raw data supporting the findings of this study can 
be found in Additional file  1. The blood flow data is 
summarized in Table  2 with the compliance and pulsa-
tion data summarized in Table 3. The arterial inflow, SSS 
outflow, AVD and arterial stroke volume data for the 
normal elderly and NPH patients has been previously 
published [17]. The ST outflow and both venous sinus 
stroke volumes were not previously published and were 
calculated from the original raw data retrieved from the 
archive DVD discs. The MS and normal young data has 
not been previously published.
Blood flow
As expected, there was a non-significant reduction in 
arterial inflow with normal aging between the two con-
trol groups, with the reduction in blood flow being 
approximately 3  ml/min/year. The sagittal sinus showed 
a reduced outflow with aging in proportion to the inflow. 
There was no significant alteration in the percentage of 
the blood flow returned by each sinus compared to the 
arterial inflow. The multiple sclerosis patients were com-
pared to the normal young. There was no significant dif-
ference in arterial inflow. There was a 13 % reduction in 
sagittal sinus outflow (p = 0.01), which gave a 5 % reduc-
tion in the percentage of the arterial inflow drained by 
this sinus (p = 0.05). The straight sinus flow and percent-
age return were not significantly different to the controls. 
The NPH patients were compared to the normal elderly. 
The arterial inflow, SSS and ST outflow volumes were 
significantly reduced by 20, 36 and 25  % respectively 
(p = 0.02, p = 0.0005, p = 0.05). The percentage of the 
arterial inflow returned by the SSS was reduced by 8  % 
(p = 0.03) but the ST as a percentage of the inflow was 
not significantly different from normal.
Craniospinal compliance and pulsation
There was no change in the AVD with aging. The arte-
rial stroke volume was increased by 46 % in the normal 
elderly compared to the normal young (p  =  0.0006). 
Despite the increase in arterial stroke volume, the two 
sinus stroke volumes were not significantly different 
between the control groups. However taken as a percent-
age of the arterial stroke volume both the venous stroke 
volumes were reduced with aging (p = 0.02 and p = 0.02 
respectively). In MS the AVD was reduced by 35 % com-
pared to the normal young (p  =  0.02). There was an 
increase in arterial stroke volume of 26 % (p = 0.02) but 
(See figure on previous page.) 
Fig. 1 A A FLAIR sagittal image of a 48 year old female MS patient with arrows showing some plaques within the corpus callosum but no signifi‑
cant cerebral volume loss. B A T2 sagittal image of the cervical spine in the same patient with arrows showing extensive MS plaques. C A sagittal 
post contrast T1 image with the black line showing the position of the venous acquisition passing through the sagittal sinus (large arrow) and 
straight sinus (small arrow). The white line is the arterial acquisition passing through the skull base. D The localizer image from the arterial acquisition 
showing the carotid arteries just above foramen lacerum (horizontal arrows) and the mid basilar artery (vertical arrow). E The phase image from the 
venous acquisition showing the sagittal sinus (large arrow) and straight sinus (small arrow). F The arterial flow graph from the same patient. The hori-
zontal line represents the mean flow velocity. Where the mean velocity transects the flow graph is the start and end of systole. The grey area above 
the line represents the arterial stroke volume which for the three arteries combined was 1184 µL. The vertical line represents the midpoint of the two 
transection points and is the midpoint of the primary arterial wave i.e. 213 mS. G The sagittal sinus flow graph from the same patient. The horizontal 
line is the mean flow velocity. The grey area is the sinus stroke volume which is 118 µL or 10 % of the arterial stroke volume. The vertical line is the 
midpoint of the two transection points and is the center of the primary pulse wave i.e. 223 mS giving an AVD of 10 mS in this patient which is less 
than 10 % of normal indicating very low compliance
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a decrease in SSS and ST stroke volumes of 31 and 32 % 
respectively (p = 0.007 and p = 0.02). Thus the percent-
ages of the arterial stroke volume directed to the venous 
sinuses were greatly reduced (p = 0.0001 and p = 0.0003 
respectively). In NPH the AVD was reduced by 58  % 
(p = 0.0002) compared to the normal elderly. The arterial 
stroke volume, SSS and ST stroke volumes were reduced 
by 28, 45 and 41 % (p = 0.02 p = 0.0005 and p = 0.002 
respectively), however, as a percentage of the arterial 
stroke volume the venous stroke volumes were not sig-
nificantly altered.
Discussion
There is a hydrodynamic spectrum underlying various 
forms of dementia. Vascular dementia is associated with 
increased arterial but normal venous stroke volume [17] 
with normal craniospinal compliance [18], Alzheimer’s 
disease is associated with normal arterial and venous 
Table 2 Brain blood flow in normal, multiple sclerosis and normal pressure hydrocephalus patients
SSS sagittal sinus sinus; ST straight sinus;  %SSS percentage of arterial inflow drained by the SSS;  %ST percentage of arterial inflow drained by ST; SD standard 
deviation; *t test p value <0.05; MS multiple sclerosis; NS not significant; NPH normal pressure hydrocephalus; NY normal young; NE normal elderly; p values are 
adjusted for age
Age (years) Arterial inflow (ml/min) SSS outflow (ml/min) ST outflow (ml/min) %SSS %ST 
Normal young n = 20
 Mean 43 792 356 108 46 14
 SD 16 142 76 29 8 3
Normal elderly n = 12
 Mean 70 709 310 91 44 13
 SD 5 110 65 30 9 4
 p value NY vs NE 0.0001* NS 0.03* NS NS NS
Multiple sclerosis n = 20
 Mean 43 783 311 95 41 12
 SD 12 160 44 28 7 4
 p value MS vs NY NS NS 0.01* NS 0.05* NS
Normal pressure hydrocephalus n = 20
 Mean 74 567 197 68 36 13
 SD 7 148 49 24 9 5
 p value NPH vs NE NS 0.02* 0.0005* 0.05* 0.03* NS
Table 3 AVD and pulsation stroke volume
AVD arteriovenous delay; ms milliseconds; SV stroke volume; SSS superior sagittal sinus; ST straight sinus; SD standard deviation; *t test p value <0.05; MS multiple 
sclerosis; NPH normal pressure hydrocephalus; NS not significant; NY normal young; NE normal elderly; p values are adjusted for age
AVD (ms) Arterial SV (µL) SSS SV (µL) ST SV (µL)  %SSS SV %ST SV 
Normal young n = 20
 Mean 112 914 273 73 31 8.7
 SD 67 264 96 30 9 3.9
Normal elderly n = 12
 Mean 111 1331 308 71 23 5.6
 SD 50 374 124 20 7 1.8
 p value NY vs NE NS 0.0006* NS NS 0.02* 0.02*
Multiple sclerosis n = 20
 Mean 73 1152 188 50 16 4.4
 SD 39 350 44 30 9 3.0
 p value MS vs NY 0.02* 0.02* 0.007* 0.02* 0.0001* 0.0003*
Hydrocephalus n = 20
 Mean 47 963 170 42 19 4.4
 SD 24 375 91 26 8 2.3
 p value NPH vs NE 0.0002* 0.02* 0.0005* 0.002* NS NS
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stroke volume [17] but reduced craniospinal compliance 
[16] and normal pressure hydrocephalus is associated 
with reduced arterial and venous stroke volume and a 
very low craniospinal compliance. The multiple sclero-
sis patients in the current study show increased arterial 
but reduced venous stroke volume together with reduced 
craniospinal compliance. Therefore, MS overlaps the 
other three forms of dementia but is most closely corre-
lated with NPH.
The pulse pressure of the blood flowing from the 
arteries into the arterioles and then into the capillaries 
is normally damped as it proceeds. The pulse induces a 
change in volume of blood in the arteries over the car-
diac cycle. However, there is non-pulsatile continuous 
flow proceeding into the capillaries [17]. The mechanism 
required to bring about the change in pulsation is known 
as the windkessel effect [19]. Arterial damping depends 
on expansion of the arteries in systole and contraction in 
diastole. This removes some energy from the flow in sys-
tole and returns it in diastole. The Monro–Kellie doctrine 
states that as the skull is rigid and the CSF incompress-
ible, the volume of the arterial pulse stored in systole 
must be accommodated by the available compliance i.e. 
either the walls of the container (the dura mater) must be 
shifted to allow egress of CSF from the cranial to spinal 
cavities and/or the veins passing through the subarach-
noid space must be compressed [20]. Thus the arterial 
tree can only be as compliant as the walls of the container 
allow. It is envisaged a breakdown in the windkessel 
effect will direct greater pulse pressure into the capil-
lary beds of the neural structures leading to parenchymal 
derangement [18]. A larger CSF pulse pressure will also 
be transmitted through the thin walled veins as they 
traverse the subarachnoid space and increase the venous 
pulse pressure. For example, Alzheimer’s disease (AD) is 
associated with a reduction in AVD of 36  % [16] which 
is almost identical to the MS patients in this study. The 
arterial pulse volume in AD is 1150 µL [17] which is also 
identical to MS. Is one neurodegenerative disease related 
to the other? It was suggested an increased capillary 
pulse pressure could account for the coiling and beading 
of the capillaries as well as the basement membrane dis-
ruption found in AD [18]. In the Framingham offspring 
study, higher central arterial pulse pressure was associ-
ated with lower brain volume, white matter hyperinten-
sity and vascular and Alzheimer’s type cognitive aging 
[21]. In another study, measurements of the arterial pulse 
and the invasively-measured CSF pulse pressure were 
strongly associated with temporal lobe and hippocampal 
volume loss [22], suggesting pulse waves may damage the 
brain. Finally, Chandra suggests a common mechanism 
for the neurodegeneration found within MS and AD due 
to increased amyloid precursor protein expression in 
the axons around MS plaques [23]. The purpose of the 
current study was to measure the arterial pulsation, the 
available compliance and the outflow venous pulsation to 
determine if there is a breakdown in the windkessel effect 
in multiple sclerosis, similar to NPH.
Blood flow changes
The arterial inflow to the brain reduces throughout life. 
In a cohort of normal controls of mean age 25 year pre-
viously studied by our group, the arterial inflow was 
900 ml/min with the sagittal sinus returning 45 % of the 
arterial flow and the straight sinus 14 % [17]. In the cur-
rent study, the normal young were mean age 43 year, the 
mean arterial inflow was 792  ml/min, the sagittal sinus 
returning 46 % and straight sinus 14 % of the flow. In the 
normal elderly of average age 70 year, the arterial inflow 
was 709 ml/min, the sagittal sinus returning 44 % and the 
straight sinus 13 % of the flow. Note the percentage of the 
arterial inflow returned by each sinus has not changed 
significantly over the 40  years spanned. The arterial 
inflow is noted to have reduced by 4.2 ml/min/year from 
25 to 70 year which is similar to the findings of Stoquart–
ElSankari et al. [24].
In normal pressure hydrocephalus there is a 23  % 
reduction in arterial inflow compared to the age matched 
controls. The reduction in sagittal sinus flow is some-
what larger at 36  % giving an 8  % reduction in the per-
centage of the inflow returning via this sinus. This is in 
comparison to the straight sinus where the percentage 
of the inflow is maintained. It has been previously noted 
in NPH that there is a 29  % reduction in sagittal sinus 
flow compared to controls with a 28  % increase in flow 
following CSF diversion [25]. Further investigation into 
this effect showed that the arterial inflow was unchanged. 
This indicates there must have been increased collateral 
flow bypassing the sinus before the shunt, which returns 
back to the normal venous pathway after the shunt. This 
suggests there is an elevation in sagittal sinus pressure 
but not straight sinus pressure in NPH which is reversible 
[26].
In MS, there was no significant difference in the arte-
rial inflow between patients and controls. Some have 
suggested a reduction in total cerebral blood flow seen in 
some MS studies is due to small increases in venous pres-
sure [27]. This would appear to be unlikely given the large 
perfusion pressure reserve available to the brain. How-
ever, increasing the sagittal sinus pressure by 1–2 mm Hg 
could affect the venous outflow by increasing collat-
eral flow. Note that similar to NPH, the sagittal sinus 
returned 5 % less blood as a percentage compared to con-
trols in MS. A previous study showed further evidence of 
increased SSS pressure in MS: strain-gauge plethysmog-
raphy demonstrated a 63 % increase in the total venous 
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resistance from the head in MS patients compared with 
healthy controls [28]. Given the pressure gradient from 
the sagittal sinus to the right heart is 2.5 mm Hg [29], this 
would give an increase in sinus pressure of 1.6 mm Hg if 
the blood flow was maintained. Indeed, direct measure-
ment of the sinus pressure has shown an elevation of over 
2 mm Hg in selected MS patients [30]. So it can be seen 
that there are similarities between the blood flow in NPH 
and MS patients.
Arterial stroke volume
The arterial stroke volume is the expansion of the arte-
rial tree in systole, over and above the mean flow and 
this is the impetus for both displacement of CSF into the 
spinal canal and compression of the cortical veins [31]. 
Normal aging showed an increase in the stroke volume 
between the two control groups of 46 %. It has been pre-
viously suggested that aging is associated with reduced 
compliance in the walls of the central arteries and that 
the larger pulse pressure waves generated by aging would 
penetrate deeper into the microcirculation, microvascu-
lar disease would ensue, with the brain and kidney being 
most susceptible [32]. Note that in the present study the 
arterial stroke volume increased with aging despite the 
reduction in non-pulsatile blood flow (refuting the previ-
ously discussed assertion they are always linked [13]). In 
MS there was a 26  % increase in arterial stroke volume 
compared to the age-matched controls. Fjeldstat et  al 
[33] found patients with MS have lower central arterial 
compliance than healthy controls, which preferentially 
affects the CNS vessels. The pulse wave velocity between 
the brachial and ankle arteries is significantly higher in 
MS patients compared to controls, indicating stiffer cen-
tral arteries [34]. Both these findings place a larger pulse 
pressure wave within the carotid vessels which must be 
damped. Higher central arterial pulse pressure is also 
associated with worsening gait performance in MS but 
not controls, suggesting altered vascular compliance may 
contribute to the deterioration in physical function in MS 
[35]. In comparison, NPH is associated with a reduced 
arterial stroke volume compared to controls, indicating a 
point of difference between NPH and MS.
Arteriovenous delay
Compliance is defined as the ratio of the change in vol-
ume which occurs in a structure divided by the change 
in pressure which brings this about i.e. C = ΔV/ΔP [19]. 
Aortic compliance is estimated by measuring the time the 
pulse wave takes to travel from the brachial to the ankle 
arteries [36] because the pulse wave velocity is inversely 
proportional to compliance. Thus, craniospinal compli-
ance can be measured invasively (1) by injecting a vol-
ume of fluid into the subarachnoid space and measuring 
the change in pressure which occurs, or non-invasively 
(2) by measuring the time the pulse wave takes to trav-
erse the available space. The AVD measures between 
the arteries at the skull base and the venous sinuses. It 
could be assumed that the pulse traversed the capillary 
bed, passed along the cortical veins to directly enter the 
sinuses but this was not so. Direct measurement of the 
pulse wave timing has shown that the peak pulse in the 
cortical veins lags behind the sinuses indicating that the 
pulse volume exits the arterial tree passes into the sub-
arachnoid space and re-enters the cortical vessels just 
before their junction with the sinuses [37]. Therefore the 
pulse volume passes into the spinal canal with a minimal 
time lag [38] and then travels to the venous outflow with 
a time lag measured by the AVD. The time taken for the 
pulse to travel from the arteries to the sagittal sinus is 
thus a measure of the compliance of the arteries, suba-
rachnoid space and veins between these two places. It 
is undefined how this would directly correlate with the 
other invasive techniques used to measure craniospi-
nal compliance. From the present study, we note that 
the AVD does not change from the normal young to the 
normal elderly similar to a previous study [24] suggest-
ing the compliance of the craniospinal system remains 
unchanged with normal aging. This is in comparison with 
the findings in NPH, in which the present study shows a 
58  % reduction in AVD compared to age matched con-
trols. Previously, in a smaller cohort, the compliance 
was estimated to be reduced by 50 % in NPH [25], Mase 
et al. [39] using another MRI technique confirmed a 64 % 
reduction in craniospinal compliance in NPH. The com-
pliance as measured by the AVD was reduced in MS by 
35 % compared to age match controls, indicating another 
similarity between the patient groups being currently 
studied: i.e. both NPH and MS have reduced compliance.
In a previously published control group of average 
age 33 year, the mean CSF pulse pressure at C1/C2 was 
1.6 ± 0.6 mm Hg [40]. In one study, it has been noted the 
CSF pulse pressure in NPH is twice normal [41] and 2–3 
times normal in another study [42]. Finally, NPH patients 
who responded to shunt had intracranial pulse pres-
sures averaging over 4 mm Hg [43]. Note, that despite the 
arterial stroke volume in NPH being 28 % less than age-
matched controls in this study, the pulse pressure in the 
subarachnoid space has been shown to be twice normal 
[41, 42]. This indicates very low compliance as discussed 
above. In MS the arterial stroke volume was increased by 
26  % and the compliance as measured by the AVD was 
reduced by 35  % compared to the normal young, sug-
gesting the possibility of an increased pulse pressure in 
the subarachnoid space in MS. The literature provides 
some evidence for this, the estimated peak-to-peak pulse 
pressure gradient in the spinal canal in MS patients was 
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noted to be doubled compared to controls [44] and the 
pulse volumes were significantly increased in the epidural 
veins in the spine in adolescents with MS [45] suggesting 
an increase in spinal pulse pressure.
Local spinal canal compliance
Stivaros and Jackson noted, that displacement of CSF 
through the foramen magnum into the spinal subarach-
noid space occurs due to the high compliance of the spi-
nal arachnoid mater, accounting for at least 50 % of the 
pulse pressure volume displacement [46]. In a cohort of 
normal controls vs MS patients, the C2 stroke volume 
was reduced by 24 % [13]. The Monro–Kellie doctrine is 
essentially a restatement of the conservation of mass (if 
the arterial tree increases in volume then the CSF and 
venous volume must reduce by the same amount). If the 
spinal canal has the greater relative compliance than the 
veins then a larger percentage of the arterial stroke vol-
ume will be directed to the spine, if the veins are rela-
tively more compliant than the spinal canal then their 
stroke volume will be greater as a percentage. In MS the 
arterial stroke volume was 26 % larger than controls but 
the percentage of the volume directed to the spinal canal 
was reduced by 24 % so we can conclude the spinal canal 
is much less compliant than normal in MS. One study 
found that there is no difference in the C2 stroke vol-
ume between normal elderly (at 71 year) and NPH [47]. 
In another study, the cervical stroke volume was reduced 
by 27 % compared to controls [48]. Given there is a 28 % 
reduction in arterial pulse volume in NPH compared to 
controls, the second study showing a 27 % reduction in 
cervical stroke volume would indicate an equal reduc-
tion in relative compliance between the spinal canal and 
the veins. The first study, where the spinal canal volumes 
were equal, would indicate the veins should be of some-
what lower relative compliance than the spinal canal. 
Thus, in both MS and NPH there is a reduction in spinal 
canal compliance.
Venous sinus compliance
In this study, the normal young, direct 31 % of the arte-
rial stroke volume to the sagittal sinus and 8.7 % to the 
straight sinus. In MS this was much less i.e. 16 % of the 
arterial stroke volume was directed towards the sagittal 
sinus and 4.4  % to the straight sinus. Given the arterial 
stroke volume was larger in MS than in controls, this 
would tend to indicate that the compliance of the corti-
cal veins leading to the sinuses is very low and thus resist 
compression in MS. In NPH the percentage of the arte-
rial pulse directed to the sinuses was not significantly 
different to normal, suggesting as previously noted, that 
the reduction in compliance is probably equally shared 
between the spinal canal and veins.
A common pathophysiology of MS and NPH
There appears to be a common pathophysiological mech-
anism underlying MS and NPH. Both disorders gener-
ate collateral blood flow, bypassing the sagittal sinus, 
suggesting an increase in sinus pressure. Both disor-
ders show a decrease in compliance compared to con-
trols. Confounding the lower compliance in MS is the 
increased arterial stroke volume. Both conditions show a 
reduction in relative spinal canal and venous compliance 
but the relative changes between the spine and veins vary.
The arterial pulse pressure within the arteries of the 
neck represents a source of potential energy. In order for 
this energy to be removed from the arterial circulation 
before the capillary bed, it is necessary for the volume 
increase generated by the pulse pressure to be directed 
to the subarachnoid space and veins. If the compliance 
of the spine and veins is low, the pulse pressure damp-
ing is reduced and there is thought to be an increase in 
capillary pulse pressure, causing capillary disruption. In 
human hydrocephalus, the capillary wall shows blood–
brain barrier dysfunction with increased vesicular and 
vacuolar transport, open inter-endothelial junctions, thin 
and fragmented basement membranes and discontinu-
ous perivascular astrocytic end feet. The findings sug-
gested an inter-endothelial route either for hydrocephalic 
oedema formation or resolution [49].
In addition to the capillary bed being affected, the 
breakdown in the windkessel mechanism may lead to an 
increased pulse pressure in the veins of the brain [17]. 
NPH is associated with a doubling in the subarachnoid 
space pulse pressure [41, 42] and the current data sug-
gests an increase in subarachnoid pulse pressure may also 
occur in MS. The cortical veins and the vein of Galen are 
thin walled, so the pulse pressure within these structures 
will be identical to the CSF pulse pressure. Despite the 
suggested increase in cortical vein pulse pressure, there 
is a failure of the pulse pressure being converted into 
pulsatile flow in the veins in MS and in NPH [50]. The 
intracranial venous system is without valves so the pulse 
pressure is free to travel in both directions i.e. toward the 
sinuses and towards the smallest venules. In NPH there 
is thickening of the walls of the smallest venules which 
is termed perivenular collagenosis [51]. A similar process 
can be seen within the eyes of MS patients, which occur 
in the absence of demyelination (there is no myelin in 
the retina). Measurement of the retinal artery to retinal 
vein pulse delay (similar to the AVD) indicates the ves-
sels are reduced in compliance by 25 % in MS compared 
to controls [52]. Reducing the compliance of the venules 
will make conversion of the pulse pressure to pulsatile 
flow ineffective. Therefore, the retinal veins will have a 
high pulse pressure. The retinal veins in MS are associ-
ated with a breakdown of the blood-retinal barrier with 
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venous fluorescein leakage. Leaking venules are associ-
ated with a proteinaceous perivenous sheathing, which 
occurs especially at arterial/venous crossover points [53] 
where the venous pulse pressure would be at a maximum. 
All of these findings are analogous to those in NPH as 
already described.
If the pathophysiology between NPH and MS is so simi-
lar one might expect that there would be some overlap in 
presentation. The absolute compliance in NPH is much 
lower than MS and the intracranial pulse pressure is prob-
ably higher but there may be a few patients who present 
with both conditions. There have been a few isolated case 
reports of patients with MS who had shunt responsive 
hydrocephalus [54, 55]. It is likely that more patients exist 
but they may be misinterpreted as atrophy rather than 
NPH. Similarly, a theory has been put forward that syrin-
gomyelia secondary to Chiari I malformation develops in 
the cervical cord, due to an increase in local CSF pulse 
pressure secondary to reduced spinal canal compliance 
(pulse wave myelopathy) [56]. If this were true, then there 
should be a correlation between MS and syrinx forma-
tion in those whose spinal canal compliance dropped low 
enough. Firstly, as noted previously, the pulse volumes 
were significantly increased in the epidural veins in the 
spine in adolescents with MS [45], suggesting an increase 
in spinal pulse pressure and secondly, syringomyelia is 
noted in 4.5 % of patients with MS [57]. This suggests that 
the syrinx is more likely to be a consequence of the MS 
pathology rather than a coincidence [57].
Limitations of the method
There is no ideal plane to measure the arterial inflow with 
a single MR acquisition. A single arterial acquisition was 
required in this study to minimise the time the patient 
spent in the scanner, because the flow measurements 
were acquired after a full 40  min diagnostic MS study. 
Measured in the current plane, the carotid arteries were at 
the skull base and the extracranial carotid segments were 
excluded. However, the subarachnoid extent of the verte-
bral vessels extends from the upper surface of C1 so the 
subarachnoid vertebrals and the lower basilar artery were 
not measured. The effect was to miss some of the blood 
flow supplying the cerebellum, brainstem and spinal cord 
and also underestimate the arterial stroke volume con-
tributed by the expansion of the posterior fossa vessels. 
Effectively, the current study measured the supratentorial 
blood flow and pulsation. The alternative would have been 
to place the arterial acquisition in the neck at C2 similar to 
Qvarlander et al. [48]. However, although all of the arte-
rial flow would be measured, large segments of the extrac-
ranial carotid and vertebral arteries would have been 
added. The vessels within the subarachnoid space are con-
strained by the water bath of the CSF and the compliance 
of the walls of the container. The extracranial vessels are 
not so constrained so the neck positioning will signifi-
cantly overestimate the arterial stroke volume (the normal 
elderly in Qvarlander et al. showed an arterial stroke vol-
ume of 1.6 times the current study, despite the mean flow 
being not significantly different). The positioning of the 
venous acquisition means the venous flow and pulsation 
were also being measured supratentorially, similar to the 
arterial measurement. The neck positioning of the venous 
acquisition would exclude the comparison between the 
straight and sagittal sinuses performed by this study and 
also vastly overestimate the venous stroke volume. The 
venous stroke volume in Qvarlander et al. was 6.3 times 
the sagittal sinus stroke volume for the normal controls. 
The AVD would also have been invalid if large sections of 
compliant extracranial vessels were added.
The venous stroke volume and flow as measured rep-
resent only a portion of the total. The sagittal sinus and 
straight sinus outflow being 60  % of the arterial inflow 
in the young controls. Other blood flow and pulsation 
leaves the brain via the basal sinuses, ophthalmic veins, 
emissary veins and direct connections to the transverse 
and sigmoid sinuses. This is the reason the percentage 
of the arterial stroke volume directed to the spinal canal, 
sagittal sinus and straight sinuses can all be reduced in 
MS because the extra is directed to the basal sinuses. 
Although the relative compliances of the spinal canal and 
the sinuses measured by the current study were reduced 
(and the total compliance reduced), if the basal sinuses 
were unchanged in compliance then a larger percent-
age of the pulse volume would be directed to them, or 
the Monro–Kellie doctrine would be violated. There is 
no way to measure the basal sinus components directly 
except by subtraction of the known stroke volumes. The 
acquisition planes as used were identical to the earlier 
studies [16, 17] and are therefore directly comparable.
The measurement of the AVD attempts to find the cen-
tre of each pulse wave, however, due to the waves not 
being perfect sine waves the centre based on the timing 
(as currently used) may not represent the centre of the 
volume of blood expansion but the error is expected to 
be small.
Conclusions
The pulsation pathophysiology of MS is similar to NPH 
suggesting that there may be an underlying pulse wave 
encephalopathy component to this disease which is being 
masked by the more obvious inflammatory overlay. It is 
uncertain if the neurodegenerative component is primary 
or secondary but the pulse wave encephalopathy which 
ensues could account for some of the chronic symptoms 
of MS and treatments aimed at altering the pulse wave 
propagation should be investigated.
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